Please assess the completion status of the following clinical trial:

Trial Title: Study : LEVOBUPIVACAINE Versus Placebo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age \> 18 years~* all patients requiring a non-urgent caesarian done according to the Misgav-Ladach technique~Exclusion Criteria:~* Patients requiring very urgent caesarian~* allergic to levobupivacaïne~* with previous history of alcoholism or drug addiction~* with severe hypotension or an ischemic cardiopathy badly compensated or thyrotoxicoses~* treated with first generation of IMAO (monoamine oxidase inhibitor) or with anti-arrhytmia drugs with anesthesic activity

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): patient who received levobupivacaïne
- 2 (Type: PLACEBO_COMPARATOR): patient who received placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).